Free Trial

Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Decreases By 13.8%

Aveanna Healthcare logo with Medical background

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 1,250,000 shares, a decrease of 13.8% from the December 31st total of 1,450,000 shares. Based on an average daily volume of 245,700 shares, the short-interest ratio is presently 5.1 days. Currently, 2.3% of the company's stock are short sold.

Wall Street Analyst Weigh In

Separately, Truist Financial reduced their target price on shares of Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating for the company in a research note on Monday, January 6th.

Get Our Latest Report on Aveanna Healthcare

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its stake in Aveanna Healthcare by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company's stock valued at $7,287,000 after purchasing an additional 63,190 shares during the last quarter. State Street Corp raised its stake in shares of Aveanna Healthcare by 0.9% during the third quarter. State Street Corp now owns 1,039,920 shares of the company's stock valued at $5,408,000 after acquiring an additional 9,446 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Aveanna Healthcare by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company's stock valued at $2,406,000 after acquiring an additional 17,522 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its stake in shares of Aveanna Healthcare by 297.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company's stock valued at $1,848,000 after acquiring an additional 265,969 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Aveanna Healthcare by 155.8% during the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company's stock valued at $438,000 after acquiring an additional 96,600 shares during the last quarter. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Stock Performance

AVAH traded up $0.18 on Wednesday, reaching $4.94. The company had a trading volume of 68,734 shares, compared to its average volume of 165,958. The company's fifty day moving average is $4.86 and its 200 day moving average is $4.99. Aveanna Healthcare has a fifty-two week low of $2.00 and a fifty-two week high of $6.19. The stock has a market cap of $954.56 million, a P/E ratio of -14.45 and a beta of 2.24.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.03. The firm had revenue of $509.02 million for the quarter, compared to analyst estimates of $495.80 million. During the same quarter in the prior year, the business posted ($0.05) EPS. On average, sell-side analysts expect that Aveanna Healthcare will post -0.06 EPS for the current year.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Featured Articles

Should You Invest $1,000 in Aveanna Healthcare Right Now?

Before you consider Aveanna Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.

While Aveanna Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

As Wall Street's 2025 predictions roll in, Goldman Sachs is focusing on manufacturing, energy, and domestic producers as key sectors for growth.

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines